探讨乙酰半胱氨酸改善大鼠杏仁核相关的自闭症及其机制
Exploring the Effect of N-Acetylcysteine on Amygdala Related Autism in Rats and Its Mechanism
DOI: 10.12677/acm.2025.15113360, PDF,    科研立项经费支持
作者: 蓝莉萍*:赣州市第三人民医院女二区,江西 赣州
关键词: 杏仁核自闭症丙戊酸乙酰半胱氨酸Amygdala Autism Valproate N-Acetylcysteine
摘要: 目的:探讨全身性给予乙酰半胱氨酸对于自闭症的治疗作用及其机制。方法:怀孕母鼠在怀孕的12.5天时腹腔注射一剂500 mg/kg丙戊酸。在出生第21天,给予子代公鼠进行行为测试,包括社交行为测试(SI)、开放空间行为测试(OF)、高架十字迷宫测试(EPM)。测试结束后,腹腔注射给予乙酰半胱氨酸150 mg/kg或是生理食盐水,每天一次,为期七天。七天后给予大鼠相同的行为测试。二十四小时后,处死大鼠,进行电生理纪录。结果:慢性给予丙戊酸子代乙酰半胱氨酸之后,恢复社交时间和次数以及达到缓解焦虑行为的效果。于杏仁核脑片中,丙戊酸子代有较高的mEPSCs频率和较低的PPF比值,给予NAC治疗后得以恢复。结论:给予乙酰半胱氨酸治疗之后,改善丙戊酸子代的社交障碍、过度焦虑和增强的突触前兴奋性神经传导。
Abstract: Objective: To explore the therapeutic effect and mechanism of systemic administration of N-acetylcysteine on autism. Methods: Pregnant rats were intraperitoneally injected with 500 mg/kg valproic acid at 12.5 days of pregnancy. On the 21st day of birth, the offspring male rats were given behavioral tests, including the social behavior test (SI), open field behavior test (OF), and elevated plus maze test (EPM). After the test, N-acetylcysteine 150 mg/kg or physiological salt water was injected intraperitoneally once a day for seven days. The rats were given the same behavioral test seven days later. Twenty four hours later, rats were killed and electrophysiological records were made. Results: after chronic administration of levulinic acid and N-acetylcysteine, the time and frequency of social recovery and the effect of relieving anxiety behavior were achieved. In amygdala brain slices, valproic acid progeny showed a high frequency of mEPSCs and a low PPF ratio, which recovered after treatment with NAC. Conclusions: after the treatment with acetylcysteine, the social disorder, excessive anxiety and enhanced presynaptic excitatory nerve conduction of valproate offspring can be improved.
文章引用:蓝莉萍. 探讨乙酰半胱氨酸改善大鼠杏仁核相关的自闭症及其机制[J]. 临床医学进展, 2025, 15(11): 2376-2387. https://doi.org/10.12677/acm.2025.15113360

参考文献

[1] 曾泳添, 陈日玲, 农雪艳, 等. 数字疗法在自闭症筛查到干预的临床研究进展与挑战[J]. 中国全科医学, 2025, 28(14): 1702-170.
[2] de la Torre-Ubieta, L., Won, H., Stein, J.L. and Geschwind, D.H. (2016) Advancing the Understanding of Autism Disease Mechanisms through Genetics. Nature Medicine, 22, 345-361. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, F., Gao, Y., Liu, Z., Cheng, Z., Liu, S., Zhang, Y., et al. (2025) Boosting 2-Arachidonoylglycerol, but Not N-Acylethanolamine, Ameliorates Autism Symptoms in VPA-Exposed Rats by Modulating Abnormal Neuroinflammation. Neuropharmacology, 276, Article 110501. [Google Scholar] [CrossRef] [PubMed]
[4] Pangrazzi, L., Cerilli, E., Balasco, L., Dall’O’, G.M., Chelini, G., Pastore, A., et al. (2024) N-Acetylcysteine Counteracts Immune Dysfunction and Autism-Related Behaviors in the Shank3b Mouse Model of Autism Spectrum Disorder. Antioxidants, 13, Article 1390. [Google Scholar] [CrossRef] [PubMed]
[5] Loomis, S., Silva, D.G., Savopoulos, R., Cilia, J., Li, J., Davis, M.D., et al. (2025) Behavioral and Transcriptomic Effects of a Novel Cannabinoid on a Rat Valproic Acid Model of Autism. Neuropharmacology, 273, Article 110450. [Google Scholar] [CrossRef] [PubMed]
[6] Takyi, E., Nirmalkar, K., Adams, J. and Krajmalnik-Brown, R. (2025) Interventions Targeting the Gut Microbiota and Their Possible Effect on Gastrointestinal and Neurobehavioral Symptoms in Autism Spectrum Disorder. Gut Microbes, 17, Article 2499580. [Google Scholar] [CrossRef] [PubMed]
[7] Ostrolenk, A., Boisvert, M. and Mottron, L. (2025) What Do Autistic Children Who Are Interested in Letters and Numbers Do with Them? A Qualitative Study. International Journal of Qualitative Studies on Health and Well-Being, 20, Article 2500851. [Google Scholar] [CrossRef] [PubMed]
[8] Shareef, A.A., Kheder, A.H., Albarzinji, N., Karim, K.J., Smail, S.W., Mahmood, A.A., et al. (2025) Oxidative Markers and SOD Variant: Predictors of Autism Severity and Susceptibility. Future Science OA, 11, Article 2483628. [Google Scholar] [CrossRef] [PubMed]
[9] 谢雅静, 时晓敏, 颜世敢, 等. 肠道菌群与精神类疾病相关性研究进展[J]. 中国药理学通报, 2022, 38(11): 1617-1622.
[10] Simões de Oliveira, L., O’Leary, H.E., Nawaz, S., Loureiro, R., Davenport, E.C., Baxter, P., et al. (2024) Enhanced Hippocampal LTP but Normal NMDA Receptor and AMPA Receptor Function in a Rat Model of CDKL5 Deficiency Disorder. Molecular Autism, 15, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
[11] Kurahashi, H., Kunisawa, K., Tanaka, K.F., Kubota, H., Hasegawa, M., Miyachi, M., et al. (2025) Autism Spectrum Disorder-Like Behaviors Induced by Hyper-Glutamatergic NMDA Receptor Signaling through Hypo-Serotonergic 5-HT1A Receptor Signaling in the Prefrontal Cortex in Mice Exposed to Prenatal Valproic Acid. Neuropsychopharmacology, 50, 739-750. [Google Scholar] [CrossRef] [PubMed]
[12] Xia, Q., Walker, A.K., Song, C., Wang, J., Singh, A., Mobley, J.A., et al. (2023) Effects of Heterozygous Deletion of Autism-Related Gene Cullin-3 in Mice. PLOS ONE, 18, e0283299. [Google Scholar] [CrossRef] [PubMed]
[13] Tumdam, R., Hussein, Y., Garin-Shkolnik, T. and Stern, S. (2024) NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models. International Journal of Molecular Sciences, 25, Article 12366. [Google Scholar] [CrossRef] [PubMed]
[14] Williams, P.G., Sears, L., Watson, W.H., Gunaratnam, B., Feygin, Y., Wright, S.P., et al. (2025) Glutathione, Vitamin C, and Cysteine Use in Autistic Children with Disruptive Behavior: A Double-Blind, Placebo-Controlled Crossover Pilot Study. Journal of Developmental & Behavioral Pediatrics, 46, e17-e24. [Google Scholar] [CrossRef] [PubMed]
[15] Shamabadi, A., Karimi, H., Arabzadeh Bahri, R., Motavaselian, M. and Akhondzadeh, S. (2024) Emerging Drugs for the Treatment of Irritability Associated with Autism Spectrum Disorder. Expert Opinion on Emerging Drugs, 29, 45-56. [Google Scholar] [CrossRef] [PubMed]